mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.1 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.1 |